MJ Prototype /
22 November 2016Americas

IntelGenx secures licence to erectile dysfunction drug from Eli Lilly

Canada-based oral drug company IntelGenx has secured a licence from Eli Lilly to a patent covering tadalafil.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at